Status:
COMPLETED
During-exercise Physiological Effects of Nasal High-flow in Patients With Chronic Obstructive Pulmonary Disease
Lead Sponsor:
ADIR Association
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Chronic obstructive pulmonary disease is a major cause of disability and mortality worldwide. This disease progressively leads to dyspnea and exercise capacity impairment. Pulmonary rehabilitation tea...
Detailed Description
Experimental design: Patients referred for pulmonary rehabilitation will be approached to participate in this study. Eligible patients who agree to participate in the study and sign informed consent ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age \> 18years and \< 80years;
- Chronic obstructive pulmonary disease Gold III-IV;
- Stable (no exacerbation) in the past 4 weeks;
- Referred for pulmonary rehabilitation (no cardiac, neurological, orthopedic, neuromuscular, psychological or psychiatric contra indication).
- Non-inclusion Criteria:
- Acute exacerbation of chronic obstructive pulmonary disease between the incremental cardiopulmonary exercise testing and inclusion;
- Tracheostomy;
- Nasal high flow intolerance;
- Pregnancy or likely to be;
- Unable to consent;
- Patients under guardianship.
Exclusion
Key Trial Info
Start Date :
November 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2021
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04014868
Start Date
November 22 2019
End Date
October 10 2021
Last Update
March 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ADIR Association
Bois-Guillaume, France, 76230